Health Care & Life Sciences » Biotechnology | RXi Pharmaceuticals Corp.

RXi Pharmaceuticals Corp.

RXi Pharmaceuticals Corp.
Stock Exchange NASDAQ Stock Market
EPS
$3.25
Market Cap
$6.43 M
Shares Outstanding
4.38 M
Public Float
3.64 M

Profile

Address
257 Simarano Drive
Marlborough Massachusetts 01752
United States
Employees -
Website http://www.rxipharma.com
Updated 09/14/2018
RXi Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Financials

View All

Geert Cauwenbergh
President, CEO, CFO & Director
Robert J. Bitterman
Chairman